Expression of erbB receptors mRNA in thyroid tissues

Biochimica et Biophysica Acta - General Subjects

Volumn 1673, Issue 3, 2004, Pages 194-200

  Kato, Seiya ^a   Kobayashi, Takako ^a   Yamada, Kouji ^a   Nishii, Kazuhiro ^a   Sawada, Hirohide ^a   Ishiguro, Hiroshi ^a   Itoh, Mitsuyasu ^a   Funahashi, Hiroomi ^b   Nagasaka, Akio ^a  

^a FUJITA HEALTH UNIVERSITY   (Japan)

^b Gifu Prefectural Tajimi Hospital   (Japan)

Author keywords

erbB; Expression; Thyroid

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; EPIDERMAL GROWTH FACTOR RECEPTOR 3; EPIDERMAL GROWTH FACTOR RECEPTOR 4; MESSENGER RNA;

ADOLESCENT; ADULT; AGED; ARTICLE; CARCINOGENESIS; CARCINOMA CELL; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GRAVES DISEASE; HUMAN; HUMAN TISSUE; MALE; NORTHERN BLOTTING; PAPILLARY CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; THYROID CARCINOMA; THYROID TUMOR;

ADOLESCENT; ADULT; AGED; BASE SEQUENCE; BLOTTING, NORTHERN; DNA PRIMERS; FEMALE; HUMANS; MALE; MIDDLE AGED; RECEPTOR, ERBB-2; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; THYROID GLAND;

EID: 3242745266     PISSN: 03044165     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbagen.2004.04.016     Document Type: Article

References (40)

1. Akslen L.A., Varhaug J.E. Oncoproteins and tumor progression in papillary thyroid carcinoma: presence of epidermal growth factor receptor, c-erbB-2 protein, estrogen receptor related protein, p21-ras protein, and proliferation indicators in relation to tumor recurrences and patient survival. Cancer. 76:1995;1643-1654
2. Burden S., Yarden Y. Neuregulins and their receptors: a versatile signaling module in organogenesis and oncogenesis. Neuron. 18:1997;847-855
3. Soomro S., Shousha S., Taylor P., Shepard H.M., Feldmann M. c-erbB-2 expression in different histological types of invasive breast carcinoma. J. Clin. Pathol. 44:1991;211-214
4. Labriola L., Salatino M., Proietti C.J., Pecci A., Coso O.A., Kornblihtt A.R., Charreau E.H., Elizalde P.V. Heregulin induces transcriptional activation of the progesterone receptor by a mechanism that requires functional erbB-2 and mitogen-activated protein kinase activation in breast cancer cells. Mol. Cell. Biol. 23:2003;1095-1111
5. McCarthy N.J., Yang X., Linnoila I.R., Merino M.J., Hewitt S.M., Parr A.L., Paik S., Steinberg S.M., Hartmann D.P., Mourali N., Levine P.H., Swain S.M. Microvessel density, expression of estrogen receptor alpha, MIB-1, p53, and c-erbB-2 in inflammatory breast cancer. Clin. Cancer Res. 8:2002;3857-3862
6. McKenzie S.J., DeSombre K.A., Bast B.S., Hollis D.R., Whitaker R.S., Berchuck A., Boyer C.M., Bast R.C. Jr. Serum levels of HER-2 neu (C-erbB-2) correlate with overexpression of p185neu in human ovarian cancer. Cancer. 71:1993;3942-3946
7. Kono K., Takahashi A., Ichihara F., Sugai H., Fujii H., Matsumoto Y. Impaired antibody-dependent cellular cytotoxicity mediated by herceptin in patients with gastric cancer. Cancer Res. 62:2002;5813-5817
8. Lee J.C., Wang S.T., Chow N.H., Yang H.B. Eur, J. Investigation of the prognostic value of coexpressed erbB family members for the survival of colorectal cancer patients after curative surgery. Eur. J. Cancer. 38:2002;1065-1071
9. Schneider P.M., Hung M.C., Chiocca S.M., Manning J., Zhao X.Y., Fang K., Roth J.A. Differential expression of the c-erbB-2 gene in human small cell and non-small cell lung cancer. Cancer Res. 49:1989;4968-4971
10. Weiner D.B., Nordberg J., Robinson R., Nowell P.C., Gazdar A., Greene M.I., Williams W.V., Cohen J.A., Kern J.A. Expression of the neu gene-encoded protein (P185neu) in human non-small cell carcinomas of the lung. Cancer Res. 50:1990;421-425
11. Yusa K., Sugimoto Y., Yamori T., Yamamoto T., Toyoshima K., Tsuruo T. Low metastatic potential of clone from murine colon adenocarcinoma 26 increased by transfection of activated c-erbB-2 gene. J. Natl. Cancer Inst. 82:1990;1633-1636
12. Burstein H.J., Harris L.N., Gelman R., Lester S.C., Nunes R.A., Kaelin C.M., Parker L.M., Ellisen L.W., Kuter I., Gadd M.A., Christian R.L., Kennedy P.R., Borges V.F., Bunnell C.A., Younger J., Smith B.L., Winer E.P. Preoperative therapy with trastuzumab and paclitaxel followed by sequential adjuvant doxorubicin/cyclophosphamide for HER2 overexpressing stage II or III breast cancer: a pilot study. J. Clin. Oncol. 21:2003;46-53
13. Bell R. What can we learn from Herceptin trials in metastatic breast cancer? Oncology. 63(Suppl. 1):2002;39-46
14. Haugen D.R., Akslen L.A., Varhaug J.E., Lillehaug J.R. Expression of c-erbB-2 protein in papillary thyroid carcinomas. Br. J. Cancer. 65:1992;832-837
15. Ensinger C., Prommegger R., Kendler D., Gabriel M., Spizzo G., Mikuz G., Kremser R. Her2/neu expression in poorly-differentiated and anaplastic thyroid carcinomas. Anticancer Res. 23:2003;2349-2353
16. Ensinger C., Prommegger R., Kendler D., Gabriel M., Spizzo G., Mikuz G., Kremser R. Her2/neu expression in C-cell hyperplasia and medullary thyroid carcinomas. Anticancer Res. 23:2003;2241-2243
17. Kremser R., Obrist P., Spizzo G., Erler H., Kendler D., Kemmler G., Mikuz G., Ensinger C. Her2/neu overexpression in differentiated thyroid carcinomas predicts metastatic disease. Virchows Arch. 442:2003;322-328
18. Haugen D.R., Akslen L.A., Varhaug J.E., Lillehaug J.R. Expression of c-erbB-3 and c-erbB-4 proteins in papillary thyroid carcinomas. Cancer Res. 56:1996;1184-1188
19. Sugg S.L., Ezzat S., Zheng L., Rosen I.B., Freeman J.L., Asa S.L. Cytoplasmic staining of erbB-2 but not mRNA levels correlates with differentiation in human thyroid neoplasia. Clin. Endocrinol. 49:1998;629-637
20. Scott G.K., Dodson J.M., Montgomery P.A., Johnson R.M., Sarup J.C., Wong W.L., Ullrich A., Shepard H.M., Benz C.C. p185HER2 signal transduction in breast cancer cells. J. Biol. Chem. 266:1991;14300-14305
21. Badley J.E., Bishop G.A., St. John T., Frelinger J.A. A simple, rapid method for the purification of poly A+RNA. BioTechniques. 6:1988;114-116
22. Ullrich A., Coussens L., Hayflick J.S., Dull T.J., Gray A., Tam A.W., Lee J., Yarden Y., Libermann T.A., Schlessinger J., Downward J., Mayes E.L.V., Whittle N., Waterfield M.D., Seeburg P.H. Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells. Nature. 309:1984;418-425
23. Papewalis J., Nikitin A.Y.u., Rajewsky M.F. G to A polymorphism at amino acid codon 655 of the human erbB-2/HER2 gene. Nucleic Acids Res. 19:1991;5452
24. Kraus M.H., Issing W., Miki T., Popescu N.C., Aaronson S.A. Links isolation and characterization of ERBB3, a third member of the ERBB/epidermal growth factor receptor family: evidence for overexpression in a subset of human mammary tumors. Proc. Natl. Acad. Sci. U. S. A. 86:1989;9193-9197
25. Agus D.B., Akita R.W., Fox W.D., Lewis G.D., Higgins B., Pisacane P.I., Lofgren J.A., Tindell C., Evans D.P., Maiese K., Scher H.I., Sliwkowski M.X. Targeting ligand-activated ErbB2 signaling inhibits breast and prostate tumor growth. Cancer Cell. 2:2002;127-137
26. Suo Z., Risberg B., Karlsson M.G., Villman K., Skovlund E., Nesland J.M. The expression of EGFR family ligands in breast carcinomas. Int. J. Surg. Pathol. 10:2002;91-99
27. Miura K., Doura H., Aizawa T., Tada H., Seno M., Yamada H., Kawano K. Solution structure of betacellulin, a new member of EGF-family ligands. Biochem. Biophys. Res. Commun. 294:2002;1040-1046
28. Aasland R., Lillehaug J.R., Male R., Josendal O., Varhaug J.E., Kleppe K. Expression of oncogenes in thyroid tumours: coexpression of c-erbB2/neu and c-erbB. Br. J. Cancer. 57:1988;358-363
29. Soda G., Antonaci A., Bosco D., Nardoni S., Melis M. Expression of bcl-2, c-erbB-2, p53, and p21 (waf1-cip1) protein in thyroid carcinomas. J. Exp. Clin. Cancer Res. 18:1999;363-367
30. Utrilla J.C., Martin-Lacave I., San Martin M.V., Fernandez-Santos J.M., Galera-Davidson H. Expression of c-erbB-2 oncoprotein in human thyroid tumours. Histopathology. 34:1999;60-65
31. Martin-Lacave I., Utrilla J.C. Expression of a neu/c-erbB-2-like product in neuroendocrine cells of mammals. Histol. Histopathol. 15:2000;1027-1033
32. Geisler S., Lønning P.E., Aas T., Johnsen H., Fluge Ø., Faksvåg Haugen D., Lillehaug J.R., Akslen L.A., Børresen-Dale A.L. Influence of TP53 gene alterations and c-erbB-2 expression on the response to treatment with doxorubicin in locally advanced breast cancer. Cancer Res. 61:2001;2505-2512
33. Fluge Ø., Akslen L.A., Haugen D.R., Varhaug J.E., Lillehaug J.R. Expression of heregulins and associations with the ErbB family of tyrosine kinase receptors in papillary thyroid carcinomas. Int. J. Cancer. 87:2000;763-770
34. Bieche I., Franc B., Vidaud D., Vidaud M., Lidereau R. Analyses of MYC, ERBB2, and CCND1 genes in benign and malignant thyroid follicular cell tumors by real-time polymerase chain reaction. Thyroid. 11:2001;147-152
35. Alimandi M., Romano A., Curia M.C., Muraro R., Fedi P., Aaronson S.A., Di Fiore P.P., Kraus M.H. Cooperative signaling of ErbB3 and ErbB2 in neoplastic transformation and human mammary carcinomas. Oncogene. 10:1995;1813-1821
36. Syroid D.E., Maycox P.R., Burrola P.G., Liu N., Wen D., Lee K.F., Lemke G., Kilpatrick T.J. Cell death in the Schwann cell lineage and its regulation by neuregulin. Proc. Natl. Acad. Sci. U. S. A. 93:1996;9229-9234
37. Crovello C.S., Lai C., Cantley L.C., Carraway K.L. III Differential signaling by the epidermal growth factor-like growth factors neuregulin-1 and neuregulin-2. J. Biol. Chem. 273:1998;26954-26961
38. Jones J.T., Akita R.W., Sliwkowski M.X. Binding specificities and affinities of egf domains for ErbB receptors. FEBS Lett. 447:1999;227-231
39. Stortelers C., van De Poll M.L., Lenferink A.E., Gadellaa M.M., van Zoelen C., van Zoelen E.J. Epidermal growth factor contains both positive and negative determinants for interaction with ErbB-2/ErbB-3 heterodimers. Biochemistry. 41:2002;4292-4301
40. Sweeney C., Fambrough D., Huard C., Diamonti A.J., Lander E.S., Cantley L.C., Carraway K.L. III Growth factor-specific signaling pathway stimulation and gene expression mediated by ErbB receptors. J. Biol. Chem. 276:2001;22685-22698